Suppr超能文献

黄金时间:墨西哥西北部癌症儿童伴发热性中性粒细胞减少症患者给予抗生素的充分时间与可持续性及临床结局的关系。

The Golden Hour: Sustainability and Clinical Outcomes of Adequate Time to Antibiotic Administration in Children with Cancer and Febrile Neutropenia in Northwestern Mexico.

机构信息

Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, TN.

Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of California San Diego, La Jolla, CA.

出版信息

JCO Glob Oncol. 2021 May;7:659-670. doi: 10.1200/GO.20.00578.

Abstract

PURPOSE

Time to antibiotic administration (TTA) is a commonly used standard of care in pediatric cancer settings in high-income countries. Effective interventions to improve outcomes in cancer patients with febrile neutropenia (FN) often address timely and appropriate antibiotic administration. We assessed the effectiveness of a locally adapted multimodal strategy in decreasing TTA in a resource-constrained pediatric cancer center in Mexico.

METHODS

We conducted a prospective observational study between January 2014 and April 2019. A three-phase (phase I: execution, phase II: consolidation, phase III: sustainability) multimodal improvement strategy that combined system change, FN guideline development, education, auditing and monitoring, mentoring, and dissemination was implemented to decrease TTA in inpatient and ambulatory areas. Sustainability factors were measured by using a validated tool during phases I and III.

RESULTS

Our population included 105 children with cancer with 204 FN events. The baseline assessment revealed that only 50% of patients received antibiotics within 60 minutes of prescription (median time: inpatient, 75 minutes; ambulatory, 65 minutes). After implementing our improvement strategy, the percentage of patients receiving antibiotics within 60 minutes of prescription increased to 88%. We significantly decreased median TTA in both clinical areas during the three phases of the study. In phase III (sustainability), the median TTA was 40 minutes ( = .023) in the inpatient area and 30 minutes ( = .012) in the ambulatory area. The proportion of patients with sepsis decreased from 30% (baseline) to 5% (phase III) ( = .001).

CONCLUSION

Our results demonstrate that locally adapted multimodal interventions can reduce TTA in resource-constrained settings. Mentoring and dissemination were novel components of the multimodal strategy to improve FN-associated clinical outcomes. Improving local infrastructure, ongoing monitoring systems, and leadership engagement have been key factors to achieving sustainability during the 5-year period.

摘要

目的

抗生素给药时间(TTA)是高收入国家儿科癌症环境中常用的护理标准。改善发热性中性粒细胞减少症(FN)癌症患者结局的有效干预措施通常涉及及时和适当的抗生素给药。我们评估了在墨西哥资源有限的儿科癌症中心中,对当地适应性的多模式策略在减少 TTA 方面的效果。

方法

我们在 2014 年 1 月至 2019 年 4 月期间进行了一项前瞻性观察性研究。采用三阶段(阶段 I:执行,阶段 II:巩固,阶段 III:可持续性)多模式改进策略,该策略结合了系统变革、FN 指南制定、教育、审核和监测、指导以及传播,以减少住院和门诊区域的 TTA。在阶段 I 和 III 期间,使用经过验证的工具来衡量可持续性因素。

结果

我们的人群包括 105 例患有癌症的儿童和 204 例 FN 事件。基线评估显示,只有 50%的患者在处方后 60 分钟内接受抗生素治疗(中位数时间:住院,75 分钟;门诊,65 分钟)。在实施我们的改进策略后,在处方后 60 分钟内接受抗生素治疗的患者比例增加到 88%。我们在研究的三个阶段均显著缩短了两个临床区域的 TTA 中位数。在第 III 阶段(可持续性),住院区域的 TTA 中位数为 40 分钟(P =.023),门诊区域为 30 分钟(P =.012)。败血症患者的比例从 30%(基线)下降到 5%(第 III 阶段)(P =.001)。

结论

我们的结果表明,在资源有限的环境中,当地适应性的多模式干预措施可以缩短 TTA。指导和传播是改进 FN 相关临床结局的多模式策略中的新组成部分。改善当地基础设施、持续监测系统和领导层参与是在 5 年内实现可持续性的关键因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24e1/8162497/40641865b87f/go-7-go.20.00578-g001.jpg

相似文献

2
Reducing Time to Antibiotic Administration for Febrile Neutropenia in the Emergency Department.
J Oncol Pract. 2015 Nov;11(6):450-5. doi: 10.1200/JOP.2014.002733. Epub 2015 Jul 28.
4
Patient Outcomes With Febrile Neutropenia Based on Time to Antibiotics in the Emergency Department.
Pediatr Emerg Care. 2022 Jan 1;38(1):e259-e263. doi: 10.1097/PEC.0000000000002241.
6
Impact of Time-to-Antibiotic Delivery in Pediatric Patients With Cancer Presenting With Febrile Neutropenia.
JCO Oncol Pract. 2024 Feb;20(2):228-238. doi: 10.1200/OP.23.00583. Epub 2023 Dec 21.
7
8
Cohort study of the impact of time to antibiotic administration on mortality in patients with febrile neutropenia.
Antimicrob Agents Chemother. 2014 Jul;58(7):3799-803. doi: 10.1128/AAC.02561-14. Epub 2014 Apr 21.
10
Time to Antibiotic for Pediatric Oncology Patients With Febrile Neutropenia at Regional Emergency Departments.
Pediatr Emerg Care. 2022 Jan 1;38(1):e94-e99. doi: 10.1097/PEC.0000000000002160.

引用本文的文献

1
Overcoming challenges to reduce time to antibiotic therapy in febrile neutropenic children: insights from a Mexican center.
Hematol Transfus Cell Ther. 2024 Dec;46 Suppl 6(Suppl 6):S193-S201. doi: 10.1016/j.htct.2024.04.123. Epub 2024 Aug 18.
3
Impact of Time-to-Antibiotic Delivery in Pediatric Patients With Cancer Presenting With Febrile Neutropenia.
JCO Oncol Pract. 2024 Feb;20(2):228-238. doi: 10.1200/OP.23.00583. Epub 2023 Dec 21.
5
Collaboration for success: the Global Initiative for Childhood Cancer in Latin America.
Rev Panam Salud Publica. 2023 Oct 4;47:e144. doi: 10.26633/RPSP.2023.144. eCollection 2023.
6
A multimodal strategy to improve health care for pediatric patients with cancer and fever in Peru.
Rev Panam Salud Publica. 2023 Oct 4;47:e140. doi: 10.26633/RPSP.2023.140. eCollection 2023.
8
Advances in the Global Initiative for Childhood Cancer: implementation in Latin America and the Caribbean.
Rev Panam Salud Publica. 2023 Sep 25;47:e128. doi: 10.26633/RPSP.2023.128. eCollection 2023.
10
Triple-hit explanation for the worse prognosis of pediatric acute lymphoblastic leukemia among Mexican and Hispanic children.
Front Oncol. 2022 Nov 30;12:1072811. doi: 10.3389/fonc.2022.1072811. eCollection 2022.

本文引用的文献

3
Management of Patients With Fever and Neutropenia Through the Arc of Time: A Narrative Review.
Ann Intern Med. 2019 Mar 19;170(6):389-397. doi: 10.7326/M18-3192. Epub 2019 Mar 12.
4
An Initiative to Decrease Time to Antibiotics for Patients With Fever and Neutropenia.
Am J Med Qual. 2019 Mar/Apr;34(2):158-164. doi: 10.1177/1062860618792305. Epub 2018 Aug 6.
6
Implementation of a Pathway for the Treatment of Fever and Neutropenia in Pediatric Patients With Cancer.
J Pediatr Oncol Nurs. 2017 Sep/Oct;34(5):315-321. doi: 10.1177/1043454217691231. Epub 2017 Mar 1.
8
Core components for effective infection prevention and control programmes: new WHO evidence-based recommendations.
Antimicrob Resist Infect Control. 2017 Jan 10;6:6. doi: 10.1186/s13756-016-0149-9. eCollection 2017.
9
Implementation of the WHO multimodal Hand Hygiene Improvement Strategy in a University Hospital in Central Ethiopia.
Antimicrob Resist Infect Control. 2017 Jan 5;6:3. doi: 10.1186/s13756-016-0165-9. eCollection 2017.
10
Management of febrile neutropaenia: ESMO Clinical Practice Guidelines.
Ann Oncol. 2016 Sep;27(suppl 5):v111-v118. doi: 10.1093/annonc/mdw325.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验